about
Genomics and biological activity of neutrophil gelatinase-associated lipocalin in several clinical settingsLipocalin 2 (LCN2) Expression in Hepatic Malfunction and TherapyThe potential use of biomarkers in predicting contrast-induced acute kidney injuryCilostazol renoprotective effect: modulation of PPAR-γ, NGAL, KIM-1 and IL-18 underlies its novel effect in a model of ischemia-reperfusionA basic science view of acute kidney injury biomarkers.Network based analyses of gene expression profile of LCN2 overexpression in esophageal squamous cell carcinomaSerum neutrophil gelatinase-associated lipocalin and recovery of kidney graft function after transplantationLipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infectionCytoprotective Effect of Ferritin H in Renal Ischemia Reperfusion Injury.Urine/Plasma Neutrophil Gelatinase Associated Lipocalin Ratio Is a Sensitive and Specific Marker of Subclinical Acute Kidney Injury in Mice.Immunosuppression-Independent Role of Regulatory T Cells against Hypertension-Driven Renal Dysfunctions.The Caenorhabditis elegans Excretory System: A Model for Tubulogenesis, Cell Fate Specification, and PlasticityExogenous Lipocalin 2 Ameliorates Acute Rejection in a Mouse Model of Renal TransplantationThe Ligands of Neutrophil Gelatinase-Associated LipocalinInsights into cellular and molecular basis for urinary tract infection in autosomal dominant polycystic kidney disease.N-acetylcysteine plus deferoxamine for patients with prolonged hypotension does not decrease acute kidney injury incidence: a double blind, randomized, placebo-controlled trial.Effect of Rhizoma Polygoni Cuspidati and Ramulus Cinnamomi compatibility on uric acid metabolism and urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 in rats with hyperuricemia.Revisiting Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Cancer: Saint or Sinner?
P2860
Q27011425-C691F4B0-A38E-47F5-856A-87DE71C50380Q28068137-F03DD12F-53BA-4EDC-84D9-C83ADC413F08Q28078393-50030F05-18DD-421B-AC04-0D75D0921679Q28538659-5E07943B-627A-446A-B194-947C6EC94BD6Q30384522-CEAAC105-CAA6-4D22-83F9-0915CB4C6B3BQ33789015-AA18428E-D3D5-465D-95B2-2C9EB038450EQ34005432-8C0C6AF3-C542-446C-BB39-B7D7ED83B2F0Q34646648-D9AA827D-0337-4A1D-9C89-15F24F0DE9B6Q35778470-39CDED47-5B80-4087-BF13-A65FF9391091Q35908335-F047591C-B3F9-4A2B-8ADC-6D2A435B3B8CQ36070023-5CE96C89-154E-4686-9C70-697422B8D1F5Q36875639-6C1847E6-426D-4635-B235-5018522EC839Q37200856-2A3C9146-7870-4C81-ACD0-A738D784EEA1Q37238644-605FCE48-4DFE-4208-BB2C-8E703EF12DDAQ40099764-1716254B-495E-493B-B625-D57C70E60A2DQ41474972-17029723-6B5E-49C8-8F9E-3A514A2B4FCAQ51172184-E0C18337-BAD3-408F-9E9E-B034ADC1C88FQ58723325-F3697CE3-C56B-4F47-BA0F-BBE1BFBB9F52
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
NGAL-Siderocalin in kidney disease
@ast
NGAL-Siderocalin in kidney disease
@en
NGAL-Siderocalin in kidney disease
@nl
type
label
NGAL-Siderocalin in kidney disease
@ast
NGAL-Siderocalin in kidney disease
@en
NGAL-Siderocalin in kidney disease
@nl
prefLabel
NGAL-Siderocalin in kidney disease
@ast
NGAL-Siderocalin in kidney disease
@en
NGAL-Siderocalin in kidney disease
@nl
P2093
P2860
P50
P3181
P1476
NGAL-Siderocalin in kidney disease
@en
P2093
Andong Qiu
Jonathan Barasch
Thomas L Nickolas
P2860
P304
P3181
P356
10.1016/J.BBAMCR.2012.06.014
P407
P577
2012-06-19T00:00:00Z